We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Real Time PCR Assays Compared for Viral Quantification

By LabMedica International staff writers
Posted on 14 Jan 2013
The performance of three real time polymerase chain reaction assays has been compared for the quantification of polyomavirus BK.

Reactivation of latent polyomavirus BK is associated with nephropathy (PVAN) after renal transplantation and the BK viral load determinations are a highly sensitive and specific method for predicting risk for PVAN.

At the Albany Medical Center Hospital (NY, USA) a team of investigators collected 100 anticoagulated plasma specimens from 69 renal transplant patients which were analyzed with three real-time PCR (rt-PCR) assays for BK viral load determination. More...
The rt-PCR assays were evaluated in terms of linearity, dynamic range, and accuracy, against a conventional PCR with primers and probe targeting the large T antigen (TOR) (Integrated DNA Technologies, Coralville, IA, USA).

The two commercial rt-PCR assays used were the MultiCode-RTx BK (MC-RTx) virus Analyte Specific Reagents (ASR) from Luminex (Austin, TX, USA), and the MGB-Alert BKV ASR (MGB) from Epoch Biosciences (Princeton, NJ, USA). A laboratory developed assay (LDA) was also evaluated. Of the 100 specimens from 69 patients sent to the laboratory for routine polyomavirus measurements by the TOR and analyzed with all three rt-PCR assays, 76 were defined as true positive for BKV DNA and no samples were inhibitory for PCR.

The MC-RTx assay was positive for all 76 specimens whereas MGB was positive for 64 and LDA was positive for 55. The viral load range for these samples was from1.71 to 7.55 log10 copies/mL, while the median viral load was 3.01 log10 copies/mL. BKV DNA was not detected by any method in the true negative specimens. The sensitivities of the assays was 100% for MC-RTx, 84% for MGB and 72% for LDA and the specificities were 100% for all three assays.

The authors concluded that all three real-time PCR assays are reliable for measuring BKV loads for the identification of patients at risk for PVAN. These assays demonstrated superiority over the TOR with regards to precision. MC-RTx appears to have enhanced sensitivity and better performance among divergent strains of BK. The study was published on December 27, 2012, in the Journal of Clinical Virology.

Related Links:

Albany Medical Center Hospital
Integrated DNA Technologies
Luminex




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Automated Clinical Chemistry Analyzer
Envoy 500+
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.